CS186391A3 - Pharmaceuticals - Google Patents

Pharmaceuticals Download PDF

Info

Publication number
CS186391A3
CS186391A3 CS911863A CS186391A CS186391A3 CS 186391 A3 CS186391 A3 CS 186391A3 CS 911863 A CS911863 A CS 911863A CS 186391 A CS186391 A CS 186391A CS 186391 A3 CS186391 A3 CS 186391A3
Authority
CS
Czechoslovakia
Prior art keywords
methyl
group
amino
quinazolin
compound
Prior art date
Application number
CS911863A
Other languages
Czech (cs)
English (en)
Inventor
William Pendergast
Scott Howard Dickerson
Julius Vass Johnson
Robert Ferone
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CS186391A3 publication Critical patent/CS186391A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS911863A 1990-06-19 1991-06-18 Pharmaceuticals CS186391A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909013615A GB9013615D0 (en) 1990-06-19 1990-06-19 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
CS186391A3 true CS186391A3 (en) 1992-04-15

Family

ID=10677828

Family Applications (1)

Application Number Title Priority Date Filing Date
CS911863A CS186391A3 (en) 1990-06-19 1991-06-18 Pharmaceuticals

Country Status (26)

Country Link
US (4) US6090941A (es)
EP (2) EP0535034B1 (es)
JP (1) JP2966929B2 (es)
KR (1) KR0183042B1 (es)
CN (1) CN1049215C (es)
AP (1) AP218A (es)
AT (2) ATE260262T1 (es)
AU (1) AU639815B2 (es)
CA (1) CA2085589C (es)
CS (1) CS186391A3 (es)
DE (2) DE69133371T2 (es)
DK (2) DK1199307T3 (es)
ES (2) ES2211851T3 (es)
FI (1) FI925778A (es)
GB (1) GB9013615D0 (es)
HU (2) HUT62273A (es)
IE (1) IE912073A1 (es)
IL (1) IL98542A (es)
MC (1) MC2290A1 (es)
MY (1) MY107001A (es)
NO (1) NO924929D0 (es)
NZ (1) NZ238582A (es)
PL (1) PL169927B1 (es)
PT (1) PT98021B (es)
WO (1) WO1991019700A1 (es)
ZA (1) ZA914676B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
WO2000055166A1 (en) 1999-03-16 2000-09-21 Regents Of The University Of California Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
AU7526901A (en) * 2000-06-09 2001-12-24 Gilead Sciences Inc Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
US6677352B1 (en) * 2001-09-26 2004-01-13 Yamin Wang 1,6-naphthyridine derivatives and their use to treat diabetes and related disorders
CN100434425C (zh) * 2005-03-09 2008-11-19 首都师范大学 4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (en) * 2005-08-17 2007-02-21 Dan Stoicescu Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes
CN101321806B (zh) 2005-12-05 2011-01-26 日东电工株式会社 聚谷氨酸盐-氨基酸轭合物及方法
GB0525069D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
JP2010505811A (ja) 2006-10-04 2010-02-25 ファイザー・プロダクツ・インク カルシウム受容体アンタゴニストとしてのピリド［４，３−ｄ］ピリミジン−４（３Ｈ）−オン誘導体
EP1958632A1 (en) 2007-02-14 2008-08-20 Dan Stoicescu Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
US20080279782A1 (en) * 2007-05-09 2008-11-13 Nitto Denko Corporation Polymers conjugated with platinum drugs
US20080279778A1 (en) * 2007-05-09 2008-11-13 Nitto Denko Corporation Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
CN101678123B (zh) 2007-05-09 2014-07-16 日东电工株式会社 包含疏水性化合物和聚氨基酸结合物的组合物
US8517760B2 (en) 2007-08-20 2013-08-27 Ford Global Technologies, Llc Cord wrap and power plug receptacle arrangement for inflator
US8146622B2 (en) 2007-08-20 2012-04-03 Ford Global Technologies, Llc Switch and hose-valve connection arrangement for vehicle temporary mobility kit
WO2010138955A2 (en) 2009-05-29 2010-12-02 University Of Florida Research Foundation, Inc. Methods and compositions for treating neoplasia
CN101580501B (zh) * 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) * 2009-12-22 2011-06-30 協和発酵キリン株式会社 三環系化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST862021I4 (en) * 1969-01-27 1969-05-27 Defensive publication
DE2202847A1 (de) * 1971-02-05 1972-08-17 Apaw Sa Speiseeismaschine,insbesondere fuer Familiengebrauch,Kleinbetriebe od.dgl.
GB2065653B (en) * 1979-12-19 1983-03-09 Nat Res Dev Anti-cancer quinazoline derivatives
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4603186A (en) 1985-10-21 1986-07-29 The Standard Oil Company Tetrapolymers containing indene
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4902624A (en) * 1987-11-23 1990-02-20 Eastman Kodak Company Temperature cycling cuvette
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5405851A (en) * 1990-06-19 1995-04-11 Burroughs Wellcome Co. Pharmaceutical compounds

Also Published As

Publication number Publication date
NO924929L (no) 1992-12-18
HU211265A9 (en) 1995-11-28
HUT62273A (en) 1993-04-28
ATE222243T1 (de) 2002-08-15
MY107001A (en) 1995-08-30
EP0535034A1 (en) 1993-04-07
US5663337A (en) 1997-09-02
NO924929D0 (no) 1992-12-18
DE69133088D1 (de) 2002-09-19
WO1991019700A1 (en) 1991-12-26
CN1058208A (zh) 1992-01-29
CA2085589C (en) 2001-12-18
DE69133371D1 (de) 2004-04-01
ES2178632T3 (es) 2003-01-01
EP1199307A1 (en) 2002-04-24
EP1199307B1 (en) 2004-02-25
JPH05507704A (ja) 1993-11-04
CA2085589A1 (en) 1991-12-20
AU639815B2 (en) 1993-08-05
EP0535034B1 (en) 2002-08-14
FI925778A0 (fi) 1992-12-18
ES2211851T3 (es) 2004-07-16
GB9013615D0 (en) 1990-08-08
KR930701415A (ko) 1993-06-11
DE69133371T2 (de) 2005-01-27
KR0183042B1 (ko) 1999-05-01
IE912073A1 (en) 1992-01-01
PT98021A (pt) 1992-04-30
AP218A (en) 1992-09-27
IL98542A0 (en) 1992-07-15
AP9100283A0 (en) 1991-07-31
ATE260262T1 (de) 2004-03-15
DK1199307T3 (da) 2004-06-14
US5661155A (en) 1997-08-26
ZA914676B (en) 1993-02-24
DE69133088T2 (de) 2003-03-20
CN1049215C (zh) 2000-02-09
MC2290A1 (fr) 1993-07-14
PL169927B1 (pl) 1996-09-30
JP2966929B2 (ja) 1999-10-25
US6306865B1 (en) 2001-10-23
US6090941A (en) 2000-07-18
HU9204011D0 (en) 1993-03-29
FI925778A (fi) 1992-12-18
IL98542A (en) 1995-05-26
DK0535034T3 (da) 2002-12-09
PT98021B (pt) 1998-11-30
AU8094391A (en) 1992-01-07
NZ238582A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
CS186391A3 (en) Pharmaceuticals
US20050171101A1 (en) Phenanthridinones as parp inhibitors
EP0831829B1 (en) Heterocyclic ring-fused pyrimidine derivatives
FI113765B (fi) Menetelmä uusien antiproliferatiivisten 5-substituoitujen kinatsoliiniyhdisteiden valmistamiseksi
JP7157764B2 (ja) 新規なピペリジン－２，６－ジオン誘導体及びその用途
AU2006271297B2 (en) Novel heterocyclidene acetamide derivative
JP2000508657A (ja) チロシンキナーゼの不可逆的阻害剤
US6407116B1 (en) Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
BR112013004750B1 (pt) Derivados de quinolina e quinoxalina como inibidores da cinase
CN107614503A (zh) 稠环或三环芳基嘧啶化合物用作激酶抑制剂
WO2016022460A1 (en) Potent dual brd4-kinase inhibitors as cancer therapeutics
CN104936963B (zh) 作为蛋白激酶抑制剂的硫醚衍生物
SK283952B6 (sk) Pyrido [2,3-D]pyrimidíny a farmaceutické kompozície na ich báze
CA3093323A1 (en) Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof
US5405851A (en) Pharmaceutical compounds
US6762188B1 (en) Pharmaceutically active benzoquinazoline compounds
CN104860890A (zh) T790m突变型egfr的抑制剂及其在制备抗肿瘤药物中的应用
AU680431B2 (en) 2,5-disubstituted isoquindazole-6-(2H)-ones
KR870000279B1 (ko) 피리도 [1,4] 벤조디아제핀 및 [2-[(니트로피리디닐) 아미노]페닐] 아릴메타논의 제조방법
WO1994003439A1 (en) Antiproliferative tricyclic compounds
CN117285527A (zh) 一种噌啉类par4拮抗剂及其医药应用